dihexa retracted paper controversy This morning, @novartis announced that del-brax met the primary and key secondary endpoints in the biomarker cohort of the Phase 1/2 FORTITUDE study. The results showed reductions in biomarkers associated with DUX4 Two and a half years
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12























![Necrotic Ooze [Secret Lair Drop Series] Dragon's Maze Promos](https://cdn.shopify.com/s/files/1/0117/3900/4994/files/58cbcf51-3824-4ab3-89e3-cdcc1a0c7267.png?v=1759852909)



